Pharmacokinetic Results Of a Feasibility and Phase II Study (ITCC 021) On Bortezomib (BTZ) In Pediatric Relapsed ALL: Lack Of Significant Penetration Of BTZ In The Cerebrospinal Fluid

Autor: Kaspers, Gertjan, Mathot, Ron *, Ramnarain, Satianand *, Niewerth, Denise *, Locatelli, Franco, De Bont, Eveline S.J.M, Fagioli, Franca *, Rohrlich, Pierre *, von Stackelberg, Arend, Zwaan, Michel
Zdroj: In Blood 15 November 2013 122(21):1439-1439
Databáze: ScienceDirect